user

Liposomal Amphotericin B drug access for the treatment of leishmaniasis in Brazil

被引：7
|
作者：
Mistro, Sostenes [1 ,2 ]
Rodrigues, Marlon [2 ]
Rosa, Lorena [2 ]
Camargo, Marianne [2 ]
Badaro, Roberto [1 ,3 ]
机构：
[1] Univ Fed Bahia, Program Postgrad Med & Hlth, Salvador, BA, Brazil
[2] Univ Fed Bahia, Multidisciplinary Inst Hlth, Vitoria Da Conquista, BA, Brazil
[3] Univ Fed Bahia, Dept Med & Diag, Salvador, BA, Brazil
来源：
TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2016年 / 21卷 / 06期
关键词：
leishmaniasis; Brazil; liposomal amphotericin B; access to medication; pharmacoeconomics; developing countries; VISCERAL LEISHMANIASIS; COMBINATION THERAPIES; EMULSION;
D O I：
10.1111/tmi.12697
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：692 / 693
页数：2
相关论文
共 50 条
  • [31] US food and drug administration approval of liposomal amphotericin B for the treatment of visceral leishmaniasis: A model for orphan drug development
    Richard D. Pearson
    Selma M. B. Jeronimo
    Susan M. Lareau
    [J]. Current Infectious Disease Reports, 1999, 1 (5) : 415 - 416
  • [32] Two cases of successful treatment of multilesional cutaneous leishmaniasis with liposomal amphotericin B
    Butsch, Florian
    Faulde, Michael
    Debus, Andrea
    Bogdan, Christian
    von Stebut, Esther
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (01): : 83 - 85
  • [33] Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B
    Tavil, Betul
    Secmeer, Gulten
    Oezen, Hasan
    Cengiz, Ali Bulent
    Uenal, Sule
    Guergey, Aytemiz
    [J]. TURKISH JOURNAL OF PEDIATRICS, 2008, 50 (01) : 67 - 69
  • [34] Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome)
    Davidson, RN
    diMartino, L
    Gradoni, L
    Giacchino, R
    Gaeta, GB
    Pempinello, R
    Scotti, S
    Cascio, A
    Castagnola, E
    Maisto, A
    Gramiccia, M
    diCaprio, D
    Wilkinson, RJ
    Bryceson, ADM
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) : 938 - 943
  • [35] US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis - Editorial response
    Berman, JD
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (01) : 49 - 51
  • [36] Single-dose liposomal amphotericin B: an effective treatment for visceral leishmaniasis
    Sinha, Prabhat Kumar
    Bhattacharya, Sujit
    [J]. LANCET GLOBAL HEALTH, 2014, 2 (01): : E7 - E8
  • [37] Desensitization to liposomal amphotericin B in a patient with tonsillar leishmaniasis
    Alicandro, T.
    Orsinetti, S.
    Lippolis, D.
    Liberati, S.
    Iannaccone, R.
    Moscatelli, G. L.
    Larne, D.
    Cortellini, G.
    [J]. ALLERGY, 2023, 78
  • [38] Different liposomal amphotericin B formulations for visceral leishmaniasis
    Dorlo, Thomas P. C.
    Balasegaram, Manica
    [J]. LANCET GLOBAL HEALTH, 2014, 2 (08): : E449 - E449
  • [39] LEISHMANIASIS OF THE TONGUE TREATED WITH LIPOSOMAL AMPHOTERICIN-B
    BAILY, GG
    PITT, MA
    CURRY, A
    HABOUBI, NY
    TUFFIN, JR
    MANDAL, BK
    [J]. JOURNAL OF INFECTION, 1994, 28 (03) : 327 - 331
  • [40] Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review
    Mosimann, Vincent
    Neumayr, Andreas
    Paris, Daniel H.
    Blum, Johannes
    [J]. ACTA TROPICA, 2018, 182 : 246 - 250
12345